| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |